2009
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, Panel A. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. Journal Of Pain 2009, 10: 113-130.e22. PMID: 19187889, PMCID: PMC4043401, DOI: 10.1016/j.jpain.2008.10.008.Peer-Reviewed Original ResearchConceptsChronic opioid therapyChronic noncancer painOpioid therapyNoncancer painMultidisciplinary expert panelExpert panelSystematic reviewHigh-dose opioid therapyOpioid-related adverse effectsAdverse effectsOpioid management plansDiscontinuation of therapyAmerican Pain SocietyUse of opioidsUse of methadoneMonitoring of patientsOpioid rotationBreakthrough painOpioid prescribingDose escalationPain SocietyPatient selectionRisk stratificationClinical guidelinesOpioid abuse
1999
Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications.
Namkoong K, Farren CK, O'Connor PG, O'Malley SS. Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. The Journal Of Clinical Psychiatry 1999, 60: 449-53. PMID: 10453799, DOI: 10.4088/jcp.v60n0706.Peer-Reviewed Original ResearchConceptsMedication Event Monitoring SystemMedication compliancePill countAlcohol dependenceOpen-label studyPill-taking behaviorSample of patientsEvent Monitoring SystemMeasurement of complianceEstimates of complianceCompliant groupPharmacotherapy researchTreatment outcomesClinical utilityCompliance rateNaltrexoneClinical implicationsOverall outcomeDrinking outcomesPatientsMEMS dataOutcomesCountTreatmentCompliance